ArticleCureus2026
Artificial Intelligence Should Not Prescribe Alone: A Risk-Stratified Pharmacy Governance Framework for Agentic Clinical Systems.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Agentic clinical artificial intelligence (AI) is moving beyond conversational assistance towards systems capable of generating medication-related recommendations and structured clinical actions. Although recent models have shown strong performance in simulated disease-management and medication-reasoning tasks, benchmark performance does not establish the safety of autonomous prescribing. Medication use depends on patient-specific information, local formularies, medicine availability, monitoring capacity, clinical workflows, and professional accountability. This editorial argues that medication-related AI should be governed according to clinical risk. Lower-risk functions may support medication reconciliation, monitoring and patient communication, whereas treatment initiation, dose adjustment, antimicrobial selection, therapeutic substitution and deprescribing should require explicit pharmacist and prescriber validation. Local prospective evaluation, transparent documentation, version control, incident monitoring, and sufficient professional authority are essential. Agentic AI may offer meaningful clinical support in medication-related workflows, but its role in prescribing should remain pharmacist-governed, locally validated, and auditable rather than autonomous.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.